IFLR1000

Search results

Narrow your search

Result types
Article type
Jurisdiction
Practice area
Industry sector
Bar admission

Showing 6571 - 6580 of 11096 for "Private equity" with applied filters

News & Analysis

Romania: RTPR advises SARMIS Capital on the acquisition of a majority stake in BMF Grup

28 June 2023 by Radu Tărăcilă Pădurari Retevoescu - Allen & Overy - Romania

RTPR has assisted private equity fund SARMIS Capital in relation to the acquisition of a majority shareholding stake in BMF Grup, the largest integrated facility management company on the Romanian market.
News & Analysis

Finland: Roschier advises Metso in the acquisition of Ab A. Häggblom Oy

28 June 2023 by Roschier - Finland

Metso has agreed to acquire Ab A. Häggblom Oy, a privately owned Finnish engineering and manufacturing company providing mining truck bodies and buckets. Roschier represents Metso in the transaction.
News & Analysis

Argentina: The third edition of Bruchou & Funes de Rioja Legal Week 2023 is here

22 June 2023 by Bruchou & Funes de Rioja - Argentina

The annual event that brings together professionals and prominent leaders in the legal field.
News & Analysis

Netherlands: AKD welcomes five new partners

01 June 2023 by AKD

AKD has announced the appointment of five new partners in its Dutch and Luxembourg offices.
News & Analysis

Greece: Zepos & Yannopoulos advises Thrivest on its equity investment in Attica Bank

22 May 2023 by Zepos & Yannopoulos

Thrivest Holding Ltd, an investment company owned by individual investors, namely Messrs. Dimitrios Mpakos, Ioannis Kaimenakis and Alexandros Exarchou, acquired on 28 April 2023 a 4.91% minority stake in Attica Bank, a medium size Greek bank that has been struggling to raise regulatory capital for more than a year, by subscribing for rump shares in Attica Bank’s €473.3 mln share capital increase.
News & Analysis

Ukraine: Ilyashev & Partners Achieves a Positive Decision for Clients in a Bankruptcy Case worth over UAH 1 billion

10 May 2023 by Ilyashev & Partners

On 24 April 2023 the Economic Court of Kyiv closed the proceedings in the bankruptcy case against Serhii Tyshchenko, the beneficiary of the bankrupt Fortuna-Bank.
News & Analysis

United States: Nelson Mullins Opens New Office in Chicago and Expands Cleveland Office

26 April 2023 by Nelson Mullins Riley & Scarborough

Nelson Mullins Riley & Scarborough LLP, a full-service national law firm, is opening a Chicago office as well as expanding the firm’s Cleveland office with seven litigation partners from Benesch. Four partners join the firm in its new Chicago office, while three partners join the Cleveland office.
News & Analysis

Romania: RTPR advises AROBS on Future WorkForce acquisition

26 April 2023 by Radu Tărăcilă Pădurari Retevoescu - Allen & Overy

RTPR has assisted AROBS Transilvania Software, an important Romanian company that provides software services and solutions in various industries and the largest tech company listed on the Bucharest Stock Exchange, in relation to the acquisition of the Future WorkForce Global group from Cluj-Napoca, specialised in providing complex business process automation solutions.
News & Analysis

CMS Expert Guide to Private Placement of Funds Rules and Law – Chapter Greece

24 April 2023 by Bahas Gramatidis & Partners

We are proud to announce that Dimitris Emvalomenos, Lawyer LL.M., Mediator, Dep. Managing Partner and Maria Tranoudi, Lawyer, Senior Associate of Bahas, Gramatidis & Partners Law Firm, are the authors of Chapter Greece in the latest publication "CMS Expert Guide to Private Placement of Funds Rules and Law”.
News & Analysis

Mexico: GC represented SK Capital Partners in the acquisition of Apotex Pharmaceutical Holdings Inc., a Canadian pharmaceutical company that produces high-quality, affordable medicines

24 April 2023 by Gonzalez Calvillo

We represented SK Capital Partners, a private investment firm focused in the pharmaceutical sector, in the acquisition of Apotex Pharmaceutical Holdings Inc. (“Apotex”), a Canadian pharmaceutical company that produces high-quality, affordable medicines across all major therapeutic areas for patients around the world.
Load more